Sumatriptan and Vasoconstriction - a phase IV clinical study of FDA data

Summary:

Vasoconstriction is reported as a side effect among people who take Sumatriptan (sumatriptan succinate), especially for people who are female, 50-59 old, also take Acetaminophen, and have Headache.

The phase IV clinical study analyzes which people have Vasoconstriction when taking Sumatriptan. It is created by eHealthMe based on reports of 17,179 people who have side effects when taking Sumatriptan from the FDA, and is updated regularly.

What is Sumatriptan?

Sumatriptan has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 18,158 Sumatriptan users. Check the latest studies of Sumatriptan.

What is Vasoconstriction?

Vasoconstriction (constriction of blood vessels, which increases blood pressure) is found to be associated with 126 drugs and 339 conditions by eHealthMe. Check the latest studies of Vasoconstriction.

On Jan, 07, 2026

17,179 people reported to have side effects when taking Sumatriptan.
Among them, 10 people (0.06%) have Vasoconstriction.

Could Sumatriptan cause Vasoconstriction?

Among these 10 people:

What is the gender of people who have Vasoconstriction when taking Sumatriptan? *

female: 100 %
male: 0.0 %

What is the age of people who have Vasoconstriction when taking Sumatriptan? *

What are other drugs people take besides Sumatriptan? *

Caffeine: 2 people, 20.00%
Acetaminophen: 2 people, 20.00%
Aspirin: 1 person, 10.00%

What are other side effects people have besides Vasoconstriction? *

Acute Myocardial Infarction (acute heart attack): 4 people, 40.00%
Visual Field Defect: 3 people, 30.00%
Retinal Ischaemia (lack of blood supply to retina): 3 people, 30.00%
Chest Pain: 3 people, 30.00%
Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 3 people, 30.00%
Transient Global Amnesia (a temporary short-term memory loss): 3 people, 30.00%
High Blood Cholesterol: 2 people, 20.00%
Visual Acuity Reduced (reduced clearness of vision): 2 people, 20.00%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 2 people, 20.00%
Eye Oedema (swelling or thickening of the macula, the area of the retina responsible for central vision): 2 people, 20.00%

What are the existing conditions these people have? *

High Blood Pressure: 2 people, 20.00%
Headache (pain in head): 2 people, 20.00%
Pain: 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan and have Vasoconstriction?

- Check whether Vasoconstriction is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sumatriptan:

Sumatriptan (18,158 reports)

Browse all side effects of Sumatriptan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vasoconstriction:

Vasoconstriction (126 drugs)

Browse all the conditions that are associated with Vasoconstriction:

Vasoconstriction (339 conditions)

Drugs similar to Sumatriptan and Vasoconstriction :

How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate (the active ingredients of Sumatriptan) and Sumatriptan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.